THE VALUE OF VOLUMETRIC MEASUREMENT OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) TO ASSESS THE THERAPY RESPONSE

被引:0
|
作者
Tutic, M.
Frauenfelder, T. [1 ]
Schramm, A. [2 ]
Goetti, R. P. [3 ]
Weder, W.
Marincek, B. [5 ]
Opitz, I. [4 ]
机构
[1] Inst Diagnost Radiol, Zurich, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Div Radiol, Zurich, Switzerland
[4] Univ Zurich Hosp, Dept Thorac Surg, CH-8091 Zurich, Switzerland
[5] Inst Radiol, Zurich, Switzerland
关键词
D O I
10.1016/S0169-5002(09)70273-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [1] The value of volumetric measurement of malignant pleural mesothelioma (MPM) to assess the therapy response
    Tutic, Michaela
    Frauenfelder, Thomas
    Goetti, Robert
    Schramm, Alexandra
    Weder, Walter
    Marincek, Borut
    Stahel, Rolf
    Opitz, Isabelle
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S461 - S461
  • [2] Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM)
    Servais, Elliot L.
    Colovos, Christos
    Suzuki, Kei
    Velez, Marissa
    Rodriguez, Luis
    Sima, Camelia
    Rusch, Valerie W.
    Sadelain, Michel
    Adusumilli, Prasad S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S36 - S36
  • [3] Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
    Frauenfelder, T.
    Tutic, M.
    Weder, W.
    Goetti, R. P.
    Stahel, R. A.
    Seifert, B.
    Opitz, I.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 162 - 168
  • [4] MULTIMODALITY THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA (MPM): SINGLE INSTITUTIONAL EXPERIENCE
    Kadota, Y.
    Yates, D. H.
    Spratt, P.
    Pendlebury, S.
    Dhital, K.
    Stone, E.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S31 - S31
  • [5] Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
    Malec, M.
    Desai, A.
    Waxman, I.
    Karrison, T.
    Rose, B.
    Mendoza, A.
    Gadiraju, M.
    Straus, C.
    Churpek, J.
    Kindler, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S759 - S760
  • [6] Malignant pleural mesothelioma (MPM): Trimodality therapy in a single center.
    Taverna, C
    Stahel, RA
    Bodis, S
    Russi, EW
    Weder, W
    ANNALS OF ONCOLOGY, 2000, 11 : 123 - 123
  • [7] LACK OF RESPONSE TO CHEMOTHERAPY FOR PREVIOUSLY TREATED MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S638 - S639
  • [8] Malignant pleural mesothelioma (MPM) -: the Italian experience
    Crinó, L
    Benedetti, G
    LUNG CANCER, 2004, 45 : S137 - S138
  • [9] Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax
    Kuramochi, Masami
    Muraoka, Takuma
    Shinonaga, Mayumi
    Ohtani, Haruo
    Kuraoka, Setsuo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [10] Blood tests in malignant pleural mesothelioma (MPM).
    Yoneda, Kazue
    Tanaka, Fumihiro
    Kondo, Nobuyuki
    Hashimoto, Masaki
    Takuwa, Teruhisa
    Matsumoto, Seiji
    Okumura, Yoshitomo
    Tsubota, Noriaki
    Sato, Ayuko
    Tsujimura, Tohru
    Tabata, Chiharu
    Nakano, Takashi
    Hasegawa, Seiki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)